Coya Therapeutics, Inc. — Form 8-K/A
Filed August 7, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 28/100
What the filing says
Coya Therapeutics filed an amended 8-K/A on 2026-08-07 disclosing Item 5.02 regarding departure of directors/officers and compensatory arrangements. The filing document itself contains no substantive details of specific departures, compensation amounts, names, or dates beyond the reporting date of 2026-03-29. The amendment appears technical in nature without disclosed material specifics.
Why this rating
Amendment is procedural/technical disclosure with no concrete material facts disclosed. Significance depends entirely on hidden details; filing provides none. Routine 8-K/A amendment.
Extracted items
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.